Romulus K Brazzell Kala Pharmaceuticals, Inc. (KALA) insider trading activity

Romulus K Brazzell is of Kala Pharmaceuticals, Inc.. Currently has a direct ownership of 83,982 shares of KALA, which is worth approximately $571,917. The most recent transaction as insider was on Jun 26, 2024, when has been sold 5,489 shares (Common Stock) at a price of $4.75 per share, resulting in proceeds of $26,072. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 84K

0% 3M change

2.13% 12M change

Total Value Held $571,917

Romulus K Brazzell Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 26 2024	SELL Open market or private sale	$26,072 $4.75 p/Share	5,489 Reduced 6.13%	83,982 Common Stock
May 31 2024	SELL Open market or private sale	$12,192 $6.09 p/Share	2,002 Reduced 2.19%	89,471 Common Stock
Jan 04 2024	SELL Open market or private sale	$10,898 $6.74 p/Share	1,617 Reduced 1.74%	91,473 Common Stock
Jan 04 2024	BUY Grant, award, or other acquisition	-	6,500 Added 6.53%	93,090 Common Stock
Jun 22 2023	BUY Grant, award, or other acquisition	-	49,356 Added 36.52%	85,808 Common Stock
May 31 2023	BUY Grant, award, or other acquisition	-	17,916 Added 32.95%	36,452 Common Stock
Jan 04 2023	SELL Open market or private sale	$2,082 $28.53 p/Share	73 Reduced 0.39%	18,536 Common Stock
Jan 04 2023	BUY Grant, award, or other acquisition	-	12,800 Added 40.75%	18,609 Common Stock
Oct 26 2022	SELL Open market or private sale	$1,699 $6.51 p/Share	261 Reduced 4.3%	5,809 Common Stock
Jun 27 2022	SELL Open market or private sale	$1,163 $0.37 p/Share	3,144 Reduced 1.09%	285,201 Common Stock
Jan 04 2022	SELL Open market or private sale	$4,555 $1.3 p/Share	3,504 Reduced 1.2%	288,345 Common Stock
Oct 26 2021	SELL Open market or private sale	$22,963 $1.8 p/Share	12,757 Reduced 4.19%	291,849 Common Stock
Jun 28 2021	SELL Open market or private sale	$17,506 $5.77 p/Share	3,034 Reduced 1.0%	300,962 Common Stock
Jan 04 2021	BUY Grant, award, or other acquisition	-	27,500 Added 8.3%	303,996 Common Stock
Oct 26 2020	BUY Grant, award, or other acquisition	-	81,000 Added 22.66%	276,496 Common Stock

RKB

Romulus K Brazzell

Watertown, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KALA shares.

Notify only if

Value

Insider Trading

Get notified when an Kala Pharmaceuticals, Inc. insider buys or sells KALA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Kala Pharmaceuticals, Inc.

Track Activities on KALA

Account